EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Persistent Exhausted T-Cell Immunity after Severe COVID-19: 6-Month Evaluation in a Prospective Observational Study

Elena Vazquez-Alejo iD, Laura Tarancon-Diez iD, Maria de la Sierra Espinar-Buitrago, Miguel Genebat, Alba Calderón, Guillermo Pérez-Cabeza iD, Esmeralda Magro-Lopez iD, Manuel Leal, Mª Ángeles Muñoz-Fernández iD

Journal of Clinical Medicine · 18.05.2023 · 12 (10) · 3539

DOI: 10.3390/jcm12103539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 18.05.2023. Verfasst von Elena Vazquez-Alejo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Section, Molecular Immuno-Biology Laboratory, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregor…. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine, European Cooperation in Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Severe COVID-19 can result in a significant and irreversible impact on long-term recovery and subsequent immune protection. Understanding the complex immune reactions may be useful for establishing clinically relevant monitoring.

Methods

Hospitalized adults with SARS-CoV-2 between March/October 2020 (n = 64) were selected. Cryopreserved peripheral blood mononuclear cells (PBMCs) and plasma samples were obtained at hospitalization (baseline) and 6 months after recovery. Immunological components’ phenotyping and SARS-CoV-2-specific T-cell response were studied in PBMCs by flow cytometry. Up to 25 plasma pro/anti-inflammatory cytokines/chemokines were assessed by LEGENDplex immunoassays. The SARS-CoV-2 group was compared to matched healthy donors.

Results

Biochemical altered parameters during infection were normalized at a follow-up time point in the SARS-CoV-2 group. Most of the cytokine/chemokine levels were increased at baseline in the SARS-CoV-2 group. This group showed increased Natural Killer cells (NK) activation and decreased CD16high NK subset, which normalized six months later. They also presented a higher intermediate and patrolling monocyte proportion at baseline. T cells showed an increased terminally differentiated (TemRA) and effector memory (EM) subsets distribution in the SARS-CoV-2 group at baseline and continued to increase six months later. Interestingly, T-cell activation (CD38) in this group decreased at the follow-up time point, contrary to exhaustion markers (TIM3/PD1). In addition, we observed the highest SARS-CoV-2-specific T-cell magnitude response in TemRA CD4 T-cell and EM CD8 T-cell subsets at the six-months time point.

Conclusions

The immunological activation in the SARS-CoV-2 group during hospitalization is reversed at the follow-up time point. However, the marked exhaustion pattern remains over time. This dysregulation could constitute a risk factor for reinfection and the development of other pathologies. Additionally, high SARS-CoV-2-specific T-cells response levels appear to be associated with infection severity.

Schlagwörter

Stichwörter der Autor:innen

SARS-CoV-2SARS-CoV-2-specific T-cell responsehospitalizationimmune exhaustion profilelong-term evolutionsevere COVID-19

Autor:innen und Institutionen

  • Immunology Section, Molecular Immuno-Biology Laboratory, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), 28007 Madrid, Spain.
  • Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Internal Medicine Department, Hospital Fátima, 41012 Sevilla, Spain.
  • Urgency Department, Hospital Viamed Santa Ángela de la Cruz, 41013 Sevilla, Spain.
  • Internal Medicine Department, Hospital Viamed Santa Ángela de la Cruz, 41013 Sevilla, Spain.

ORCID-Profile: Elena Vazquez-Alejo, Laura Tarancon-Diez, Guillermo Pérez-Cabeza, Esmeralda Magro-Lopez, Mª Ángeles Muñoz-Fernández

Förderung

  • Instituto de Salud Carlos III
  • Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine
  • European Cooperation in Science and Technology
  • Insituto de Investigación Sanitaria Gregorio Marañón

Zitieren

APA

Vazquez-Alejo, E., Tarancon-Diez, L., Espinar-Buitrago, M. S., Genebat, M., Calderón, A., Pérez-Cabeza, G., Magro-Lopez, E., Leal, M., & Muñoz-Fernández, M. Á. (2023). Persistent Exhausted T-Cell Immunity after Severe COVID-19: 6-Month Evaluation in a Prospective Observational Study. Journal of Clinical Medicine, 12(10), 3539. https://doi.org/10.3390/jcm12103539

Vancouver

Vazquez-Alejo E, Tarancon-Diez L, Espinar-Buitrago MS, Genebat M, Calderón A, Pérez-Cabeza G, et al. Persistent Exhausted T-Cell Immunity after Severe COVID-19: 6-Month Evaluation in a Prospective Observational Study. Journal of Clinical Medicine. 2023;12(10):3539. doi:10.3390/jcm12103539

BibTeX
@article{VazquezAlejo2023,
  author = {Vazquez-Alejo, Elena and Tarancon-Diez, Laura and Espinar-Buitrago, Maria de la Sierra and Genebat, Miguel and Calderón, Alba and Pérez-Cabeza, Guillermo and Magro-Lopez, Esmeralda and Leal, Manuel and Muñoz-Fernández, Mª Ángeles},
  title = {Persistent Exhausted T-Cell Immunity after Severe COVID-19: 6-Month Evaluation in a Prospective Observational Study},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {10},
  pages = {3539},
  doi = {10.3390/jcm12103539}
}
Kostenlos starten →